(Q35125320)

6 August 2017

In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone (English)

1 reference

6 August 2017

Oh JI

1

1 reference

6 August 2017

Paek KS

2

1 reference

6 August 2017

Ahn MJ

3

1 reference

6 August 2017

Kim MY

4

1 reference

6 August 2017

Hong CY

5

1 reference

6 August 2017

Kim IC

6

1 reference

6 August 2017

Kwak JH

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

1 reference

6 August 2017

40

1 reference

6 August 2017

6

1 reference

6 August 2017

1564-1568

1 reference

Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1- pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy.

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

New quinolones and gram-positive bacteria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

Quinolones in the treatment of lower respiratory tract infections

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163372

Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids

28 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8726042

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mechanisms of Fluoroquinolone Resistance in Staphylococcus aureus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8726042

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fluoroquinolone resistance an evolving national problem or just a problem for some physicians?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8726042

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMCID

163372

1 reference

6 August 2017

1 reference